Kawasaki disease: insights into pathogenesis and approaches to treatment

Area of Science:

• Pediatric Cardiology
• Immunology
• Infectious Diseases

Background:

• Kawasaki disease is a leading cause of acquired pediatric heart disease.
• It can result in severe coronary artery abnormalities, including myocardial ischemia, infarction, and death.
• Epidemiologic and genetic data suggest an infectious etiology with genetic susceptibility.

Purpose of the Study:

• To review recent advances in understanding the pathology and pathophysiology of coronary arteritis in Kawasaki disease.
• To describe current treatment approaches for Kawasaki disease.
• To highlight challenges in managing non-responsive cases and identifying high-risk patients.

Main Methods:

• Literature review of recent advances in Kawasaki disease research.
• Summary of current therapeutic strategies.
• Analysis of challenges in treatment and patient stratification.

Main Results:

• Coronary arteritis in Kawasaki disease involves complex pathologic and pathophysiologic mechanisms.
• Standard treatment includes intravenous immunoglobulin and aspirin.
• Management of non-responders and identification of high-risk patients require further research and better tools.

Conclusions:

• Understanding Kawasaki disease pathology is advancing, but causative agents remain elusive.
• Timely treatment is crucial, yet challenges persist in refractory cases.
• Further research is needed for effective management and risk stratification in diverse populations.